Delivery Order SPE2DR25D1022-SPE2DR26FQT0F
Award Date 12/29/25
Potential Completion Date 12/30/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,189.32 to AmerisourceBergen Drug Corp for the supply of Repaglinide 1 mg tablets (90-count units) under a firm fixed price contract. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement with no small...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Repaglinide 1 mg tablets in a 90-count package at a firm fixed price of $1,189.32. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child contract under its larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Repaglinide 1 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,911.34 with firm fixed pricing and an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,314.56 to supply Repaglinide 1 mg tablets (90-count units) with a completion date of December 2, 2025. This firm fixed-price contract, awarded without set-aside designation on December 1, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. This...
- The Defense Logistics Agency awarded a $2,702.96 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Repaglinide 1 mg, a diabetes medication, with performance in Conshohocken, Pennsylvania and completion by November 25, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing terms typical of the agency's pharmaceutical procurement operations. AmerisourceBergen Drug Corp, headquartered in Pennsylvania, is a major pharmaceutical distributor serving...
- This federal contract award is for the delivery of Repaglinide 1 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $7,964.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 1, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds significant Indefinite...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $61,200 to Amerisourcebergen Drug Corporation for the supply of 100 units of 0.5 mg Repaglinide tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The single day order from August 7-8, 2023 is being fulfilled under an existing indefinite-delivery/indefinite-quantity contract vehicle with the DLA, though further details regarding the base IDIQ are not provided....
- This federal contract award, with ID SPE2DB22D1017 and SPE2DB25FF6GE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,940.04 firm fixed-price delivery order is for 4567378518 - REPAGLINIDE 2 MG TABLET 100S, and has a completion date of February 26, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $6,798.50, is for the delivery of 4,563,575,086 units of the pharmaceutical product Repaglinide 1 mg Tablet in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of February 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
- <p>Defense Logistics Agency awarded a $961 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 tablets of 2 mg repaglinide, to be delivered by October 19, 2023. The order was placed under an existing contract vehicle and no set-aside provisions were specified. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania to support the Agency's medical supply needs.</p>